C07F 9 - Compounds containing elements of the 5th group of the periodic system

Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
12/2002
12/05/2002	US20020183320 For use as analgesics
12/05/2002	US20020183307 For therapy of hyperlipidemic condition
12/05/2002	US20020183211 Phosphazene compounds and lubricants containing the same
12/05/2002	US20020183196 Useful as components of catalysts accelerating telomerization of a conjugated diene and an active hydrogen compound
12/05/2002	US20020179105 Reduced ignition propensity smoking article
12/05/2002	DE10126929A1 Production of compounds with perfluoroalkanesulfonic acid residues, used e.g. in electrolytes and batteries, involves reacting perfluoroalkanesulfonic anhydride with dialkyl carbonate in presence of perfluoroalkanesulfonic acid
12/05/2002	CA2449118A1 Cdk inhibiting pyrimidines, production thereof and their use as medicaments
12/05/2002	CA2448088A1 Process for the preparation of prostaglandins and analogues thereof
12/04/2002	EP1262485A1 Process for preparing phosphoric ester
12/04/2002	EP1261612A1 Crystalline forms of antibiotic side chain intermediates
12/04/2002	EP1261592A1 Isothiazolecarboxylic acid derivatives and their use as microbicides
12/04/2002	EP1261579A1 Dehydroamino acids
12/04/2002	EP1161481B1 Optically active linear polymer used as ligand in the preparation of metallic complexes designed for asymmetric catalysis
12/04/2002	CN1383429A 含磷化合物 Phosphorus compounds
12/03/2002	US6489513 Reacting aromatic bromine compound with diphenylphosphinic chloride in a mixture of tetrahydrofuran and aromatic hydrocarbon to give a diphenylphosphine oxide, isolating, metalating; reacting with iodine, reacting with copper
12/03/2002	US6489506 Using a high molar ratio of ethylene to carbon monoxide in the gas in contact with the liquid phase to improve activity and life of the catalyst
12/03/2002	US6489502 Phosphorus oxyhalide is reacted with a polyol in the presence of a water- binding agent to produce a monomeric halophosphate intermediate, monomeric halophosphate intermediate is reacted with alcohol to produce phosphoric acid ester
12/03/2002	US6489476 Fructose-1,6-bisphosphatase enzyme inhibitors are useful in the treatment of diabetes and other conditions associated with elevated blood glucose or excess glycogen storage.
12/03/2002	US6489351 Condensed 4,5,6,7-tetrahydrobenzo[C]thiophenes as enhancer for cell differentation induction factor action
12/03/2002	US6489323 Inhibiting no production from l-arginine, as seen in disease states such as arthritis and systemic hypotension associated with septic and/or toxic shock
12/03/2002	CA2120242C Aminoalkylphosphonic acid containing ligands attached to solid supports for removal of metal ions
12/03/2002	CA2074933C Thiazole derivatives as active superoxide radical inhibitors
11/2002
11/28/2002	WO2002095373A1 Use of infrared spectroscopy for on-line process control and endpoint detection
11/28/2002	WO2002095073A1 Method for the synthesis of dna sequences
11/28/2002	WO2002094883A2 One-step process for the preparation of halide-free hydrophobic salts
11/28/2002	WO2002094840A2 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	WO2002094741A1 Preparation and use of diols
11/28/2002	WO2002094286A1 Cancerous metastasis inhibitors containing carbacyclic phosphatidic acid derivatives
11/28/2002	US20020177737 Hydroformylation of unsaturated compounds using polymeric phosphite ligands
11/28/2002	US20020177711 Coordination polymerization catalyst
11/28/2002	US20020177706 Rheumatic diseases; antiarthritic agents; antitumor agents
11/28/2002	US20020177622 Neuroprotectants; enhancing cognition
11/28/2002	US20020177609 Fatty alcohol drug conjugates
11/28/2002	US20020177600 Two or more ligand moieties covalently linked together by one or more linking groups enabling binding to multiple binding sites; increased efficacy, selectivity and duration; anti-proliferative and anticarcinogenic
11/28/2002	US20020176861 A phosphate derivative when co-administered with antigens such as vaccines for bacterial and viral diseases function as immunological adjuvant
11/28/2002	DE10153780C1 Carboxyethyl-methylphosphinic acid glycol ester preparation in high yield, for use as reactive flame retardant in polymers, by multi-stage process starting from yellow phosphorus
11/28/2002	CA2448197A1 Tricyclic dihydro-quinoline derivatives, method for preparing same and pharmaceutical compositions containing same
11/28/2002	CA2448183A1 Preparation and use of diols
11/28/2002	CA2447240A1 Method for the synthesis of dna sequences
11/27/2002	EP1260514A1 Process for the production of a phosphorus-containing organic compound
11/27/2002	EP1259521A1 Method for preparing bismuth tris-trifluoromethanesulphonate
11/27/2002	EP1259520A2 Novel purines
11/27/2002	EP1259519A1 Method for preparing sterically hindered phosphoramidates
11/27/2002	EP1259518A1 Benzofuranone stabilization of phosphate esters
11/27/2002	EP1214328A4 Chiral phosphines, transition metal complexes thereof and uses thereof in asymmetric reactions
11/27/2002	EP1091965B1 Precursors for growth of heterometal-oxide films by mocvd
11/27/2002	EP0998480B1 Nucleotide analog composition and synthesis method
11/27/2002	EP0996430B1 Nucleotide analog compositions
11/27/2002	EP0973782B1 Isocyanates modified for being provided with surfactant property, composition containing same, resulting coating
11/27/2002	EP0585267B1 Herpesvirus particle preparation and vaccine
11/27/2002	CN1382182A Flame-resistant polycarbonate moulding materials
11/27/2002	CN1382181A Flame-resistant polycarbonate ABS blends
11/27/2002	CN1382148A Solvent-free method for preparing sterically hindered phosphoramidates
11/26/2002	US6486359 Catalyst comprising a complex of a metal of subgroup viii based on a phosphinite ligand, and a method for hydroformylation
11/26/2002	US6486347 Reacting diarylphosphinobenzoic acid with an amine
11/26/2002	US6486334 Biomembrane mimetic surface coatings
11/26/2002	US6486312 Synthesis of oligonucleotides
11/26/2002	US6486228 Bis-acylphosphine oxides and acylphosphine oxides for curing photopolymerizable compositions without yellowing; use in white surface coatings, as negative photoresists, in printing plates
11/26/2002	US6486210 Such as enantiomorphs of 4-fluorostyryl-2,3,4,5,6-pentafluorobenzylsulfone; antiproliferative/anticancer agents
11/26/2002	US6486143 6-amino- or 6-hydrazino-sulphonyl-3-quinolynyl-phosphonic acid compounds
11/26/2002	US6486142 Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002	US6486141 Phosphonic acid biaryl derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
11/26/2002	US6485886 Oxime derivatives and the use thereof as latent acids
11/26/2002	US6485784 Precursors for the growth of strontium tantalum/niobium oxide films
11/26/2002	CA2099109C 5-thio-substituted benzotriazole uv-absorbers and stabilized compositions
11/21/2002	WO2002092608A2 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same
11/21/2002	WO2002092606A1 Fused imidazolidine derivatives, process for preparation of the same and use thereof
11/21/2002	WO2002092575A1 Benzimidazole compounds and antiviral uses thereof
11/21/2002	WO2002092226A1 Catalysts for nucleophilic substitution, synthesis thereof, composition containing same and use thereof
11/21/2002	WO2002092024A2 Compounds and methods for inhibiting axillary malodour
11/21/2002	WO2002059243A8 Zwitterionic gemini surfactants for use in carbon dioxide
11/21/2002	US20020173671 Process for the production of a phosphorus-containing organic compound
11/21/2002	US20020173607 Protected aminofunctionalized polymerization initiators and methods of making and using same
11/21/2002	US20020173529 Fungicide active substance combinations
11/21/2002	US20020173494 Ammonium salts of inositol hexaphosphate, and uses thereof
11/21/2002	US20020173490 Antidiabetic agents
11/21/2002	US20020173433 Non-symmetric, partially fluorinated lubricant additives
11/21/2002	US20020173419 Methods of polymerizing ethylene and styrene copolymers with substituted pyridyl amine catalysts and catalysts therefor
11/21/2002	CA2445459A1 Use of a composition of an ionic nature as a substrate reagent, a composition constituting a fluorination reagent and a method using same
11/21/2002	CA2442782A1 Catalysts for nucleophilic substitution, synthesis thereof, composition containing same and use thereof
11/20/2002	EP1258531A1 Compounds and methods for inhibiting axillary malodour
11/20/2002	EP1257695A1 Biomolecules having multiple attachment moieties for binding to a substrate surface
11/20/2002	EP1257557A1 Method for producing n-(phosphonomethyl)glycine
11/20/2002	EP1257549A2 Matrix metalloproteinase inhibitors and uses thereof
11/20/2002	EP1257361A1 PHOSPHOR, ARSENIC AND ANTIMONY COMPOUNDS BASED UPON DIARYL-ANELLATED BICYCLO 2.2.N&excl; PARENT SUBSTANCES AND CATALYSTS CONTAINING SAME
11/20/2002	EP1144422B1 Calixarene derivatives for extracting actinides
11/20/2002	EP1124832B1 Oxime derivatives and the use thereof as latent acids
11/20/2002	EP1115491A4 Catalyst complex with carbene ligand
11/20/2002	EP1112276B1 Cyclopentadienyl /phosphinimine catalyst with one and only one activatable ligand
11/20/2002	EP1082328B1 Production of optically active phospholanes
11/20/2002	EP0593603B1 Bicyclic fibrinogen antagonists
11/19/2002	US6482957 Useful as an intermediate of a carbocyclic nucleoside anti-viral agent; reacting 2-azabicyclo(2.2.1)hept-5-en-3-one with a sulfonyl halide or phosphoryl halide and then with a nucleic acid base
11/19/2002	US6482943 Quinones as disease therapies
11/19/2002	US6482914 Polyurethanes
11/19/2002	US6482865 Method for preparing colloidal solution of bismuth sodium tartrate
11/19/2002	US6482852 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof
11/19/2002	US6482848 Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
11/19/2002	US6482816 Organic arsenic compounds
11/19/2002	US6482815 Organic-arsenic compounds
11/19/2002	US6482797 N-terminal site selective inhibitors of human angiotensin conversion enzyme (ACE)

1 ... 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 ... 554